AVADEL PHARMACEUTICALS PLC — Director's Dealing 2025

Sep 16, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AVADEL PHARMACEUTICALS PLC (AVDL)
CIK: 0001012477
Period of Report: 2025-09-15

Reporting Person: Palczuk Linda (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-09-15	Stock Option (Right to Buy)	$10.83	G	11000	Disposed	2035-07-29	Ordinary Shares (11000)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$10.83	2035-07-29	Ordinary Shares (11000)	11000	Indirect

Footnotes

F1: The options shall vest in full on the earlier to occur of (a) July 29, 2026 or (b) the date of the next annual general meeting of shareholders following the date of grant, subject to the Reporting Person's continued service at such time.

F2: On September 15, 2025, the Reporting Person transferred 11,000 options to a revocable trust of which the Reporting Person is trustee.